1 Rabies Vaccine for Humans Market Overview 1.1 Rabies Vaccine for Humans Product Scope 1.2 Rabies Vaccine for Humans Segment by Type 1.2.1 Global Rabies Vaccine for Humans Sales by Type (2016 & 2021 & 2027) 1.2.2 Preventative Vaccine 1.2.3 Emergency Rabies Vaccine 1.3 Rabies Vaccine for Humans Segment by Application 1.3.1 Global Rabies Vaccine for Humans Sales Comparison by Application (2016 & 2021 & 2027) 1.3.2 Pre-exposure prophylaxis 1.3.3 Post-exposure prophylaxis 1.4 Rabies Vaccine for Humans Market Estimates and Forecasts (2016-2027) 1.4.1 Global Rabies Vaccine for Humans Market Size in Value Growth Rate (2016-2027) 1.4.2 Global Rabies Vaccine for Humans Market Size in Volume Growth Rate (2016-2027) 1.4.3 Global Rabies Vaccine for Humans Price Trends (2016-2027) 2 Rabies Vaccine for Humans Estimates and Forecasts by Region 2.1 Global Rabies Vaccine for Humans Market Size by Region: 2016 VS 2021 VS 2027 2.2 Global Rabies Vaccine for Humans Retrospective Market Scenario by Region (2016-2021) 2.2.1 Global Rabies Vaccine for Humans Sales Market Share by Region (2016-2021) 2.2.2 Global Rabies Vaccine for Humans Revenue Market Share by Region (2016-2021) 2.3 Global Rabies Vaccine for Humans Market Estimates and Forecasts by Region (2022-2027) 2.3.1 Global Rabies Vaccine for Humans Sales Estimates and Forecasts by Region (2022-2027) 2.3.2 Global Rabies Vaccine for Humans Revenue Forecast by Region (2022-2027) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 North America Rabies Vaccine for Humans Estimates and Projections (2016-2027) 2.4.2 Europe Rabies Vaccine for Humans Estimates and Projections (2016-2027) 2.4.3 China Rabies Vaccine for Humans Estimates and Projections (2016-2027) 2.4.4 Japan Rabies Vaccine for Humans Estimates and Projections (2016-2027) 2.4.5 Southeast Asia Rabies Vaccine for Humans Estimates and Projections (2016-2027) 2.4.6 India Rabies Vaccine for Humans Estimates and Projections (2016-2027) 3 Global Rabies Vaccine for Humans Competition Landscape by Players 3.1 Global Top Rabies Vaccine for Humans Players by Sales (2016-2021) 3.2 Global Top Rabies Vaccine for Humans Players by Revenue (2016-2021) 3.3 Global Rabies Vaccine for Humans Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rabies Vaccine for Humans as of 2020) 3.4 Global Rabies Vaccine for Humans Average Price by Company (2016-2021) 3.5 Manufacturers Rabies Vaccine for Humans Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Global Rabies Vaccine for Humans Market Size by Type 4.1 Global Rabies Vaccine for Humans Historic Market Review by Type (2016-2021) 4.1.1 Global Rabies Vaccine for Humans Sales Market Share by Type (2016-2021) 4.1.2 Global Rabies Vaccine for Humans Revenue Market Share by Type (2016-2021) 4.1.3 Global Rabies Vaccine for Humans Price by Type (2016-2021) 4.2 Global Rabies Vaccine for Humans Market Estimates and Forecasts by Type (2022-2027) 4.2.1 Global Rabies Vaccine for Humans Sales Forecast by Type (2022-2027) 4.2.2 Global Rabies Vaccine for Humans Revenue Forecast by Type (2022-2027) 4.2.3 Global Rabies Vaccine for Humans Price Forecast by Type (2022-2027) 5 Global Rabies Vaccine for Humans Market Size by Application 5.1 Global Rabies Vaccine for Humans Historic Market Review by Application (2016-2021) 5.1.1 Global Rabies Vaccine for Humans Sales Market Share by Application (2016-2021) 5.1.2 Global Rabies Vaccine for Humans Revenue Market Share by Application (2016-2021) 5.1.3 Global Rabies Vaccine for Humans Price by Application (2016-2021) 5.2 Global Rabies Vaccine for Humans Market Estimates and Forecasts by Application (2022-2027) 5.2.1 Global Rabies Vaccine for Humans Sales Forecast by Application (2022-2027) 5.2.2 Global Rabies Vaccine for Humans Revenue Forecast by Application (2022-2027) 5.2.3 Global Rabies Vaccine for Humans Price Forecast by Application (2022-2027) 6 North America Rabies Vaccine for Humans Market Facts & Figures 6.1 North America Rabies Vaccine for Humans Sales by Company 6.1.1 North America Rabies Vaccine for Humans Sales by Company (2016-2021) 6.1.2 North America Rabies Vaccine for Humans Revenue by Company (2016-2021) 6.2 North America Rabies Vaccine for Humans Sales Breakdown by Type 6.2.1 North America Rabies Vaccine for Humans Sales Breakdown by Type (2016-2021) 6.2.2 North America Rabies Vaccine for Humans Sales Breakdown by Type (2022-2027) 6.3 North America Rabies Vaccine for Humans Sales Breakdown by Application 6.3.1 North America Rabies Vaccine for Humans Sales Breakdown by Application (2016-2021) 6.3.2 North America Rabies Vaccine for Humans Sales Breakdown by Application (2022-2027) 7 Europe Rabies Vaccine for Humans Market Facts & Figures 7.1 Europe Rabies Vaccine for Humans Sales by Company 7.1.1 Europe Rabies Vaccine for Humans Sales by Company (2016-2021) 7.1.2 Europe Rabies Vaccine for Humans Revenue by Company (2016-2021) 7.2 Europe Rabies Vaccine for Humans Sales Breakdown by Type 7.2.1 Europe Rabies Vaccine for Humans Sales Breakdown by Type (2016-2021) 7.2.2 Europe Rabies Vaccine for Humans Sales Breakdown by Type (2022-2027) 7.3 Europe Rabies Vaccine for Humans Sales Breakdown by Application 7.3.1 Europe 129 Sales Breakdown by Application (2016-2021) 7.3.2 Europe 129 Sales Breakdown by Application (2022-2027) 8 China Rabies Vaccine for Humans Market Facts & Figures 8.1 China Rabies Vaccine for Humans Sales by Company 8.1.1 China Rabies Vaccine for Humans Sales by Company (2016-2021) 8.1.2 China Rabies Vaccine for Humans Revenue by Company (2016-2021) 8.2 China Rabies Vaccine for Humans Sales Breakdown by Type 8.2.1 China Rabies Vaccine for Humans Sales Breakdown by Type (2016-2021) 8.2.2 China Rabies Vaccine for Humans Sales Breakdown by Type (2022-2027) 8.3 China Rabies Vaccine for Humans Sales Breakdown by Application 8.3.1 China 156 Sales Breakdown by Application (2016-2021) 8.3.2 China 156 Sales Breakdown by Application (2022-2027) 9 Japan Rabies Vaccine for Humans Market Facts & Figures 9.1 Japan Rabies Vaccine for Humans Sales by Company 9.1.1 Japan Rabies Vaccine for Humans Sales by Company (2016-2021) 9.1.2 Japan Rabies Vaccine for Humans Revenue by Company (2016-2021) 9.2 Japan Rabies Vaccine for Humans Sales Breakdown by Type 9.2.1 Japan Rabies Vaccine for Humans Sales Breakdown by Type (2016-2021) 9.2.2 Japan Rabies Vaccine for Humans Sales Breakdown by Type (2022-2027) 9.3 Japan Rabies Vaccine for Humans Sales Breakdown by Application 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021) 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027) 10 Southeast Asia Rabies Vaccine for Humans Market Facts & Figures 10.1 Southeast Asia Rabies Vaccine for Humans Sales by Company 10.1.1 Southeast Asia Rabies Vaccine for Humans Sales by Company (2016-2021) 10.1.2 Southeast Asia Rabies Vaccine for Humans Revenue by Company (2016-2021) 10.2 Southeast Asia Rabies Vaccine for Humans Sales Breakdown by Type 10.2.1 Southeast Asia Rabies Vaccine for Humans Sales Breakdown by Type (2016-2021) 10.2.2 Southeast Asia Rabies Vaccine for Humans Sales Breakdown by Type (2022-2027) 10.3 Southeast Asia Rabies Vaccine for Humans Sales Breakdown by Application 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021) 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027) 11 India Rabies Vaccine for Humans Market Facts & Figures 11.1 India Rabies Vaccine for Humans Sales by Company 11.1.1 India Rabies Vaccine for Humans Sales by Company (2016-2021) 11.1.2 India Rabies Vaccine for Humans Revenue by Company (2016-2021) 11.2 India Rabies Vaccine for Humans Sales Breakdown by Type 11.2.1 India Rabies Vaccine for Humans Sales Breakdown by Type (2016-2021) 11.2.2 India Rabies Vaccine for Humans Sales Breakdown by Type (2022-2027) 11.3 India Rabies Vaccine for Humans Sales Breakdown by Application 11.3.1 India Rabies Vaccine for Humans Sales Breakdown by Application (2016-2021) 11.3.2 India Rabies Vaccine for Humans Sales Breakdown by Application (2022-2027) 12 Company Profiles and Key Figures in Rabies Vaccine for Humans Business 12.1 Novartis 12.1.1 Novartis Corporation Information 12.1.2 Novartis Business Overview 12.1.3 Novartis Rabies Vaccine for Humans Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Novartis Rabies Vaccine for Humans Products Offered 12.1.5 Novartis Recent Development 12.2 Sanofi 12.2.1 Sanofi Corporation Information 12.2.2 Sanofi Business Overview 12.2.3 Sanofi Rabies Vaccine for Humans Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Sanofi Rabies Vaccine for Humans Products Offered 12.2.5 Sanofi Recent Development 12.3 GlaxoSmithKline 12.3.1 GlaxoSmithKline Corporation Information 12.3.2 GlaxoSmithKline Business Overview 12.3.3 GlaxoSmithKline Rabies Vaccine for Humans Sales, Revenue and Gross Margin (2016-2021) 12.3.4 GlaxoSmithKline Rabies Vaccine for Humans Products Offered 12.3.5 GlaxoSmithKline Recent Development 12.4 Merck 12.4.1 Merck Corporation Information 12.4.2 Merck Business Overview 12.4.3 Merck Rabies Vaccine for Humans Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Merck Rabies Vaccine for Humans Products Offered 12.4.5 Merck Recent Development 12.5 Chengda 12.5.1 Chengda Corporation Information 12.5.2 Chengda Business Overview 12.5.3 Chengda Rabies Vaccine for Humans Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Chengda Rabies Vaccine for Humans Products Offered 12.5.5 Chengda Recent Development 12.6 Yisheng 12.6.1 Yisheng Corporation Information 12.6.2 Yisheng Business Overview 12.6.3 Yisheng Rabies Vaccine for Humans Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Yisheng Rabies Vaccine for Humans Products Offered 12.6.5 Yisheng Recent Development 12.7 Prcmise 12.7.1 Prcmise Corporation Information 12.7.2 Prcmise Business Overview 12.7.3 Prcmise Rabies Vaccine for Humans Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Prcmise Rabies Vaccine for Humans Products Offered 12.7.5 Prcmise Recent Development 12.8 VACN 12.8.1 VACN Corporation Information 12.8.2 VACN Business Overview 12.8.3 VACN Rabies Vaccine for Humans Sales, Revenue and Gross Margin (2016-2021) 12.8.4 VACN Rabies Vaccine for Humans Products Offered 12.8.5 VACN Recent Development 12.9 Changsheng 12.9.1 Changsheng Corporation Information 12.9.2 Changsheng Business Overview 12.9.3 Changsheng Rabies Vaccine for Humans Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Changsheng Rabies Vaccine for Humans Products Offered 12.9.5 Changsheng Recent Development 12.10 BCHT 12.10.1 BCHT Corporation Information 12.10.2 BCHT Business Overview 12.10.3 BCHT Rabies Vaccine for Humans Sales, Revenue and Gross Margin (2016-2021) 12.10.4 BCHT Rabies Vaccine for Humans Products Offered 12.10.5 BCHT Recent Development 12.11 Hissen 12.11.1 Hissen Corporation Information 12.11.2 Hissen Business Overview 12.11.3 Hissen Rabies Vaccine for Humans Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Hissen Rabies Vaccine for Humans Products Offered 12.11.5 Hissen Recent Development 13 Rabies Vaccine for Humans Manufacturing Cost Analysis 13.1 Rabies Vaccine for Humans Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Rabies Vaccine for Humans 13.4 Rabies Vaccine for Humans Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Rabies Vaccine for Humans Distributors List 14.3 Rabies Vaccine for Humans Customers 15 Market Dynamics 15.1 Rabies Vaccine for Humans Market Trends 15.2 Rabies Vaccine for Humans Drivers 15.3 Rabies Vaccine for Humans Market Challenges 15.4 Rabies Vaccine for Humans Market Restraints 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer

List of Tables Table 1. Global Rabies Vaccine for Humans Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027) Table 2. Global Rabies Vaccine for Humans Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027) Table 3. Global Rabies Vaccine for Humans Market Size (US$ Million) by Region: 2016 VS 2021 &2027 Table 4. Global Rabies Vaccine for Humans Sales (K Units) by Region (2016-2021) Table 5. Global Rabies Vaccine for Humans Sales Market Share by Region (2016-2021) Table 6. Global Rabies Vaccine for Humans Revenue (US$ Million) Market Share by Region (2016-2021)) Table 7. Global Rabies Vaccine for Humans Revenue Share by Region (2016-2021) Table 8. Global Rabies Vaccine for Humans Sales (K Units) Forecast by Region (2022-2027) Table 9. Global Rabies Vaccine for Humans Sales Market Share Forecast by Region (2022-2027) Table 10. Global Rabies Vaccine for Humans Revenue (US$ Million) Forecast by Region (2022-2027) Table 11. Global Rabies Vaccine for Humans Revenue Share Forecast by Region (2022-2027) Table 12. Global Rabies Vaccine for Humans Sales (K Units) of Key Companies (2016-2021) Table 13. Global Rabies Vaccine for Humans Sales Share by Company (2016-2021) Table 14. Global Rabies Vaccine for Humans Revenue (US$ Million) by Company (2016-2021) Table 15. Global Rabies Vaccine for Humans Revenue Share by Company (2016-2021) Table 16. Global Rabies Vaccine for Humans by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rabies Vaccine for Humans as of 2020) Table 17. Global Rabies Vaccine for Humans Average Price (USD/Unit) of Key Company (2016-2021) Table 18. Manufacturers Rabies Vaccine for Humans Manufacturing Sites and Area Served Table 19. Manufacturers Rabies Vaccine for Humans Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Global Rabies Vaccine for Humans Sales (K Units) by Type (2016-2021) Table 22. Global Rabies Vaccine for Humans Sales Share by Type (2016-2021) Table 23. Global Rabies Vaccine for Humans Revenue (US$ Million) Market Share by Type (2016-2021) Table 24. Global Rabies Vaccine for Humans Price (USD/Unit) by Type (2016-2021) Table 25. Global Rabies Vaccine for Humans Sales Share by Type (2022-2027) Table 26. Global Rabies Vaccine for Humans Revenue (US$ Million) Market Share by Type (2022-2027) Table 27. Global Rabies Vaccine for Humans Revenue Share by Type (2022-2027) Table 28. Global Rabies Vaccine for Humans Price (USD/Unit) by Type (2022-2027) Table 29. Global Rabies Vaccine for Humans Sales (K Units) by Application (2016-2021) Table 30. Global Rabies Vaccine for Humans Sales Share by Application (2016-2021) Table 31. Global Rabies Vaccine for Humans Revenue (US$ Million) Market Share by Application (2016-2021) Table 32. Global Rabies Vaccine for Humans Price (USD/Unit) by Application (2016-2021) Table 33. Global Rabies Vaccine for Humans Sales (K Units) by Application (2022-2027) Table 34. Global Rabies Vaccine for Humans Sales Share by Application (2022-2027) Table 35. Global Rabies Vaccine for Humans Revenue (US$ Million) Market Share by Application (2022-2027) Table 36. Global Rabies Vaccine for Humans Revenue Share by Application (2022-2027) Table 37. Global Rabies Vaccine for Humans Price (USD/Unit) by Application (2022-2027) Table 38. North America Rabies Vaccine for Humans Sales (K Units) by Company (2016-2021) Table 39. North America Rabies Vaccine for Humans Sales Market Share by Company (2016-2021) Table 40. North America Rabies Vaccine for Humans Revenue by Company (2016-2021) & (US$ Million) Table 41. North America Rabies Vaccine for Humans Revenue Market Share by Company (2016-2021) Table 42. North America Rabies Vaccine for Humans Sales by Type (2016-2021) & (K Units) Table 43. North America Rabies Vaccine for Humans Sales Market Share by Type (2016-2021) Table 44. North America Rabies Vaccine for Humans Sales by Type (2022-2027) & (K Units) Table 45. North America Rabies Vaccine for Humans Sales Market Share by Type (2022-2027) Table 46. North America Rabies Vaccine for Humans Sales by Application (2016-2021) & (K Units) Table 47. North America Rabies Vaccine for Humans Sales Market Share by Application (2016-2021) Table 48. North America Rabies Vaccine for Humans Sales by Application (2022-2027) & (K Units) Table 49. North America Rabies Vaccine for Humans Sales Market Share by Application (2022-2027) Table 50. Europe Rabies Vaccine for Humans Sales (K Units) by Company (2016-2021) Table 51. Europe Rabies Vaccine for Humans Sales Market Share by Company (2016-2021) Table 52. Europe Rabies Vaccine for Humans Revenue by Company (2016-2021) & (US$ Million) Table 53. Europe Rabies Vaccine for Humans Revenue Market Share by Company (2016-2021) Table 54. Europe Rabies Vaccine for Humans Sales by Type (2016-2021) & (K Units) Table 55. Europe Rabies Vaccine for Humans Sales Market Share by Type (2016-2021) Table 56. Europe Rabies Vaccine for Humans Sales by Type (2022-2027) & (K Units) Table 57. Europe Rabies Vaccine for Humans Sales Market Share by Type (2022-2027) Table 58. Europe Rabies Vaccine for Humans Sales by Application (2016-2021) & (K Units) Table 59. Europe Rabies Vaccine for Humans Sales Market Share by Application (2016-2021) Table 60. Europe Rabies Vaccine for Humans Sales by Application (2022-2027) & (K Units) Table 61. Europe Rabies Vaccine for Humans Sales Market Share by Application (2022-2027) Table 62. China Rabies Vaccine for Humans Sales (K Units) by Company (2016-2021) Table 63. China Rabies Vaccine for Humans Sales Market Share by Company (2016-2021) Table 64. China Rabies Vaccine for Humans Revenue by Company (2016-2021) & (US$ Million) Table 65. China Rabies Vaccine for Humans Revenue Market Share by Company (2016-2021) Table 66. China Rabies Vaccine for Humans Sales by Type (2016-2021) & (K Units) Table 67. China Rabies Vaccine for Humans Sales Market Share by Type (2016-2021) Table 68. China Rabies Vaccine for Humans Sales by Type (2022-2027) & (K Units) Table 69. China Rabies Vaccine for Humans Sales Market Share by Type (2022-2027) Table 70. China Rabies Vaccine for Humans Sales by Application (2016-2021) & (K Units) Table 71. China Rabies Vaccine for Humans Sales Market Share by Application (2016-2021) Table 72. China Rabies Vaccine for Humans Sales by Application (2022-2027) & (K Units) Table 73. China Rabies Vaccine for Humans Sales Market Share by Application (2022-2027) Table 74. Japan Rabies Vaccine for Humans Sales (K Units) by Company (2016-2021) Table 75. Japan Rabies Vaccine for Humans Sales Market Share by Company (2016-2021) Table 76. Japan Rabies Vaccine for Humans Revenue by Company (2016-2021) & (US$ Million) Table 77. Japan Rabies Vaccine for Humans Revenue Market Share by Company (2016-2021) Table 78. Japan Rabies Vaccine for Humans Sales by Type (2016-2021) & (K Units) Table 79. Japan Rabies Vaccine for Humans Sales Market Share by Type (2016-2021) Table 80. Japan Rabies Vaccine for Humans Sales by Type (2022-2027) & (K Units) Table 81. Japan Rabies Vaccine for Humans Sales Market Share by Type (2022-2027) Table 82. Japan Rabies Vaccine for Humans Sales by Application (2016-2021) & (K Units) Table 83. Japan Rabies Vaccine for Humans Sales Market Share by Application (2016-2021) Table 84. Japan Rabies Vaccine for Humans Sales by Application (2022-2027) & (K Units) Table 85. Japan Rabies Vaccine for Humans Sales Market Share by Application (2022-2027) Table 86. Southeast Asia Rabies Vaccine for Humans Sales (K Units) by Company (2016-2021) Table 87. Southeast Asia Rabies Vaccine for Humans Sales Market Share by Company (2016-2021) Table 88. Southeast Asia Rabies Vaccine for Humans Revenue by Company (2016-2021) & (US$ Million) Table 89. Southeast Asia Rabies Vaccine for Humans Revenue Market Share by Company (2016-2021) Table 90. Southeast Asia Rabies Vaccine for Humans Sales by Type (2016-2021) & (K Units) Table 91. Southeast Asia Rabies Vaccine for Humans Sales Market Share by Type (2016-2021) Table 92. Southeast Asia Rabies Vaccine for Humans Sales by Type (2022-2027) & (K Units) Table 93. Southeast Asia Rabies Vaccine for Humans Sales Market Share by Type (2022-2027) Table 94. Southeast Asia Rabies Vaccine for Humans Sales by Application (2016-2021) & (K Units) Table 95. Southeast Asia Rabies Vaccine for Humans Sales Market Share by Application (2016-2021) Table 96. Southeast Asia Rabies Vaccine for Humans Sales by Application (2022-2027) & (K Units) Table 97. Southeast Asia Rabies Vaccine for Humans Sales Market Share by Application (2022-2027) Table 98. India Rabies Vaccine for Humans Sales (K Units) by Company (2016-2021) Table 99. India Rabies Vaccine for Humans Sales Market Share by Company (2016-2021) Table 100. India Rabies Vaccine for Humans Revenue by Company (2016-2021) & (US$ Million) Table 101. India Rabies Vaccine for Humans Revenue Market Share by Company (2016-2021) Table 102. India Rabies Vaccine for Humans Sales by Type (2016-2021) & (K Units) Table 103. India Rabies Vaccine for Humans Sales Market Share by Type (2016-2021) Table 104. India Rabies Vaccine for Humans Sales by Type (2022-2027) & (K Units) Table 105. India Rabies Vaccine for Humans Sales Market Share by Type (2022-2027) Table 106. India Rabies Vaccine for Humans Sales by Application (2016-2021) & (K Units) Table 107. India Rabies Vaccine for Humans Sales Market Share by Application (2016-2021) Table 108. India Rabies Vaccine for Humans Sales by Application (2022-2027) & (K Units) Table 109. India Rabies Vaccine for Humans Sales Market Share by Application (2022-2027) Table 110. Novartis Corporation Information Table 111. Novartis Description and Business Overview Table 112. Novartis Rabies Vaccine for Humans Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 113. Novartis Rabies Vaccine for Humans Product Table 114. Novartis Recent Development Table 115. Sanofi Corporation Information Table 116. Sanofi Description and Business Overview Table 117. Sanofi Rabies Vaccine for Humans Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 118. Sanofi Rabies Vaccine for Humans Product Table 119. Sanofi Recent Development Table 120. GlaxoSmithKline Corporation Information Table 121. GlaxoSmithKline Description and Business Overview Table 122. GlaxoSmithKline Rabies Vaccine for Humans Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 123. GlaxoSmithKline Rabies Vaccine for Humans Product Table 124. GlaxoSmithKline Recent Development Table 125. Merck Corporation Information Table 126. Merck Description and Business Overview Table 127. Merck Rabies Vaccine for Humans Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 128. Merck Rabies Vaccine for Humans Product Table 129. Merck Recent Development Table 130. Chengda Corporation Information Table 131. Chengda Description and Business Overview Table 132. Chengda Rabies Vaccine for Humans Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 133. Chengda Rabies Vaccine for Humans Product Table 134. Chengda Recent Development Table 135. Yisheng Corporation Information Table 136. Yisheng Description and Business Overview Table 137. Yisheng Rabies Vaccine for Humans Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 138. Yisheng Rabies Vaccine for Humans Product Table 139. Yisheng Recent Development Table 140. Prcmise Corporation Information Table 141. Prcmise Description and Business Overview Table 142. Prcmise Rabies Vaccine for Humans Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 143. Prcmise Rabies Vaccine for Humans Product Table 144. Prcmise Recent Development Table 145. VACN Corporation Information Table 146. VACN Rabies Vaccine for Humans Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 147. VACN Description and Business Overview Table 148. VACN Rabies Vaccine for Humans Product Table 149. VACN Recent Development Table 150. Changsheng Corporation Information Table 151. Changsheng Rabies Vaccine for Humans Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 152. Changsheng Description and Business Overview Table 153. Changsheng Rabies Vaccine for Humans Product Table 154. Changsheng Recent Development Table 155. BCHT Corporation Information Table 156. BCHT Description and Business Overview Table 157. BCHT Rabies Vaccine for Humans Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 158. BCHT Rabies Vaccine for Humans Product Table 159. BCHT Recent Development Table 160. Hissen Corporation Information Table 161. Hissen Description and Business Overview Table 162. Hissen Rabies Vaccine for Humans Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 163. Hissen Rabies Vaccine for Humans Product Table 164. Hissen Recent Development Table 165. Production Base and Market Concentration Rate of Raw Material Table 166. Key Suppliers of Raw Materials Table 167. Rabies Vaccine for Humans Distributors List Table 168. Rabies Vaccine for Humans Customers List Table 169. Rabies Vaccine for Humans Market Trends Table 170. Rabies Vaccine for Humans Market Drivers Table 171. Rabies Vaccine for Humans Market Challenges Table 172. Rabies Vaccine for Humans Market Restraints Table 173. Research Programs/Design for This Report Table 174. Key Data Information from Secondary Sources Table 175. Key Data Information from Primary Sources List of Figures Figure 1. Rabies Vaccine for Humans Product Picture Figure 2. Global Rabies Vaccine for Humans Sales Market Share by Type in 2021 & 2027 Figure 3. Preventative Vaccine Product Picture Figure 4. Emergency Rabies Vaccine Product Picture Figure 5. Global Rabies Vaccine for Humans Sales Market Share by Application in 2021 & 2027 Figure 6. Pre-exposure prophylaxis Examples Figure 7. Post-exposure prophylaxis Examples Figure 8. Global Rabies Vaccine for Humans Sales, (US$ Million), 2016 VS 2021 VS 2027 Figure 9. Global Rabies Vaccine for Humans Sales Growth Rate (2016-2027) & (US$ Million) Figure 10. Global Rabies Vaccine for Humans Sales (K Units) Growth Rate (2016-2027) Figure 11. Global Rabies Vaccine for Humans Price Trends Growth Rate (2016-2027) (USD/Unit) Figure 12. Global Rabies Vaccine for Humans Revenue Market Share by Region: 2016 VS 2021 Figure 13. Global Rabies Vaccine for Humans Revenue Market Share by Region: 2021 VS 2027 Figure 14. North America Rabies Vaccine for Humans Revenue (Million USD) Growth Rate (2016-2027) Figure 15. North America Rabies Vaccine for Humans Sales (K Units) Growth Rate (2016-2027) Figure 16. Europe Rabies Vaccine for Humans Revenue (Million USD) Growth Rate (2016-2027) Figure 17. Europe Rabies Vaccine for Humans Sales (Million USD) Growth Rate (2016-2027) Figure 18. China Rabies Vaccine for Humans Revenue (Million USD) Growth Rate (2016-2027) Figure 19. China Rabies Vaccine for Humans Sales (Million USD) and Growth Rate (2016-2027) Figure 20. Japan Rabies Vaccine for Humans Revenue (Million USD) Growth Rate (2016-2027) Figure 21. Japan Rabies Vaccine for Humans Sales (Million USD) Growth Rate (2016-2027) Figure 22. Southeast Asia Rabies Vaccine for Humans Revenue (Million USD) Growth Rate (2016-2027) Figure 23. Southeast Asia Rabies Vaccine for Humans Sales (Million USD) Growth Rate (2016-2027) Figure 24. India Rabies Vaccine for Humans Revenue (Million USD) Growth Rate (2016-2027) Figure 25. India Rabies Vaccine for Humans Sales (Million USD) Growth Rate (2016-2027) Figure 26. Global 5 Largest Rabies Vaccine for Humans Players Market Share by Revenue in Rabies Vaccine for Humans: 2016 & 2020 Figure 27. Rabies Vaccine for Humans Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 28. Global Rabies Vaccine for Humans Revenue Share by Type (2016-2021) Figure 29. Global Rabies Vaccine for Humans Revenue Growth Rate by Type in 2016 & 2020 Figure 30. Global Rabies Vaccine for Humans Revenue Share by Application (2016-2021) Figure 31. Global Rabies Vaccine for Humans Revenue Growth Rate by Application in 2016 & 2020 Figure 32. North America Rabies Vaccine for Humans Sales Market Share by Type in 2020 Figure 33. North America Rabies Vaccine for Humans Sales Market Share by Application in 2020 Figure 34. Europe Rabies Vaccine for Humans Sales Market Share by Type in 2020 Figure 35. Europe Rabies Vaccine for Humans Sales Market Share by Application in 2020 Figure 36. China Rabies Vaccine for Humans Sales Market Share by Type in 2020 Figure 37. China Rabies Vaccine for Humans Sales Market Share by Application in 2020 Figure 38. Japan Rabies Vaccine for Humans Sales Market Share by Type in 2020 Figure 39. Japan Rabies Vaccine for Humans Sales Market Share by Application in 2020 Figure 40. Southeast Asia Rabies Vaccine for Humans Sales Market Share by Type in 2020 Figure 41. Southeast Asia Rabies Vaccine for Humans Sales Market Share by Application in 2020 Figure 42. India Rabies Vaccine for Humans Sales Market Share by Type in 2020 Figure 43. India Rabies Vaccine for Humans Sales Market Share by Application in 2020 Figure 44. Key Raw Materials Price Trend Figure 45. Manufacturing Cost Structure of Rabies Vaccine for Humans Figure 46. Manufacturing Process Analysis of Rabies Vaccine for Humans Figure 47. Rabies Vaccine for Humans Industrial Chain Analysis Figure 48. Channels of Distribution Figure 49. Distributors Profiles Figure 50. Bottom-up and Top-down Approaches for This Report Figure 51. Data Triangulation Figure 52. Key Executives Interviewed

Novartis Sanofi GlaxoSmithKline Merck Chengda Yisheng Prcmise VACN Changsheng BCHT Hissen